DK3901141T5 - Ny form af isoquinolin-sulfonamid - Google Patents

Ny form af isoquinolin-sulfonamid Download PDF

Info

Publication number
DK3901141T5
DK3901141T5 DK19899054.1T DK19899054T DK3901141T5 DK 3901141 T5 DK3901141 T5 DK 3901141T5 DK 19899054 T DK19899054 T DK 19899054T DK 3901141 T5 DK3901141 T5 DK 3901141T5
Authority
DK
Denmark
Prior art keywords
new form
isoquinoline sulfonamide
isoquinoline
sulfonamide
new
Prior art date
Application number
DK19899054.1T
Other languages
English (en)
Other versions
DK3901141T3 (da
Inventor
Hiroyoshi Hidaka
Kengo Sumi
Takashi Izuhara
Original Assignee
D Western Therapeutics Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by D Western Therapeutics Inst Inc filed Critical D Western Therapeutics Inst Inc
Application granted granted Critical
Publication of DK3901141T3 publication Critical patent/DK3901141T3/da
Publication of DK3901141T5 publication Critical patent/DK3901141T5/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK19899054.1T 2018-12-17 2019-12-16 Ny form af isoquinolin-sulfonamid DK3901141T5 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018235213 2018-12-17
PCT/JP2019/049099 WO2020129876A1 (ja) 2018-12-17 2019-12-16 イソキノリンスルホンアミドの新規な形態

Publications (2)

Publication Number Publication Date
DK3901141T3 DK3901141T3 (da) 2024-02-26
DK3901141T5 true DK3901141T5 (da) 2024-07-15

Family

ID=71101331

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19899054.1T DK3901141T5 (da) 2018-12-17 2019-12-16 Ny form af isoquinolin-sulfonamid

Country Status (21)

Country Link
US (1) US11427546B2 (da)
EP (1) EP3901141B9 (da)
JP (1) JP7425482B2 (da)
KR (1) KR102756093B1 (da)
CN (1) CN113195453B (da)
AU (1) AU2019402422B2 (da)
BR (1) BR112021011739A2 (da)
CA (1) CA3120751A1 (da)
DK (1) DK3901141T5 (da)
EA (1) EA202191339A1 (da)
ES (1) ES2972617T3 (da)
FI (1) FI3901141T5 (da)
HR (1) HRP20240372T2 (da)
HU (1) HUE066248T2 (da)
MX (1) MX2021007233A (da)
MY (1) MY210134A (da)
PH (1) PH12021551301A1 (da)
PL (1) PL3901141T3 (da)
PT (1) PT3901141T (da)
SG (1) SG11202105739YA (da)
WO (1) WO2020129876A1 (da)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS601776Y2 (ja) 1981-07-27 1985-01-18 株式会社 栗田機械製作所 フイルタプレスにおける濾布に対する原液供給板の取付構造
DE3943678C2 (de) * 1988-12-26 1999-11-25 Hiroyoshi Hidaka Isochinolinsulfonsäureamide, Verfahren zu deren Herstellung und diese Amide enthaltende pharmazeutische Zusammensetzung
US5340811A (en) 1990-03-08 1994-08-23 Asahi Kasei Kogyo Kabushiki Kaisha Isoquinoline-or quinoline-sulfonamide derivative and a pharmaceutical composition comprising the same
JP2899953B2 (ja) 1995-07-03 1999-06-02 旭化成工業株式会社 1−(5−イソキノリンスルホニル)ホモピペラジン塩酸塩1/2水和物
ES2142065T3 (es) 1995-07-03 2000-04-01 Asahi Chemical Ind Clorhidratos de 1-(5-isoquinoleinsulfonil)homopiperazina hidratado.
MY139797A (en) 2004-11-29 2009-10-30 Kowa Co (s)-(-)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2-methyl-1, 4-homopiperazine hydrochloride dihydrate
CA2690753C (en) 2007-07-02 2013-08-13 Asahi Kasei Pharma Corporation Sulfonamide compound and crystal thereof
PL2657227T3 (pl) 2010-12-22 2016-09-30 Nowa podstawiona pochodna izochinoliny
JP5819705B2 (ja) 2011-11-09 2015-11-24 興和株式会社 イソキノリン誘導体塩酸塩無水物結晶

Also Published As

Publication number Publication date
EP3901141B1 (en) 2024-02-07
MY210134A (en) 2025-08-28
KR102756093B1 (ko) 2025-01-21
SG11202105739YA (en) 2021-07-29
WO2020129876A1 (ja) 2020-06-25
BR112021011739A2 (pt) 2021-08-31
EP3901141B9 (en) 2024-06-19
FI3901141T3 (fi) 2024-03-01
JPWO2020129876A1 (ja) 2021-11-04
EP3901141A1 (en) 2021-10-27
HRP20240372T2 (hr) 2024-10-11
EP3901141A4 (en) 2022-07-13
MX2021007233A (es) 2021-07-15
AU2019402422A8 (en) 2021-07-01
AU2019402422B2 (en) 2025-01-30
PL3901141T3 (pl) 2024-05-27
US11427546B2 (en) 2022-08-30
CN113195453B (zh) 2024-04-30
HUE066248T2 (hu) 2024-07-28
HRP20240372T1 (hr) 2024-06-07
AU2019402422A1 (en) 2021-06-17
FI3901141T5 (fi) 2024-08-05
ES2972617T3 (es) 2024-06-13
PH12021551301A1 (en) 2022-03-28
EA202191339A1 (ru) 2021-08-27
US20220017469A1 (en) 2022-01-20
KR20210104729A (ko) 2021-08-25
DK3901141T3 (da) 2024-02-26
CN113195453A (zh) 2021-07-30
JP7425482B2 (ja) 2024-01-31
CA3120751A1 (en) 2020-06-25
PT3901141T (pt) 2024-03-04

Similar Documents

Publication Publication Date Title
DK3810581T3 (da) Krystalmodifikationer af odevixibat
HUE057414T2 (hu) Új szulfonamid karboxamid vegyületek
CL2019002503A1 (es) Compuesto de sulfamida cíclico y métodos de uso de los mismo.
EP4048010C0 (en) BANDWIDTH PORTION SWITCHING
DK3512850T3 (da) Inhibitorer af menin-mll-interaktionen
DK3468966T3 (da) Inhibitorer af menin-mll-interaktionen
DK3554240T3 (da) Kombinationer af aktive forbindelser
SI3743406T1 (sl) Modulatorji TMEM16A
DK3509581T3 (da) Formuleringer af (r)-2-amino-3-phenylpropylcarbamat
DK3749181T3 (da) Detektering af vævsbeskadigelse
DK3668851T3 (da) Fremgangsmåde til fremstilling af thiocarbonater
DK3433234T3 (da) Allosteriske modulatorer af nicotinacetylcholinreceptorer
DK3558024T3 (da) Fremstilling af beta-lactoglobulinpræparater
DK3891145T3 (da) Modulatorer af trex1
DK3072952T3 (da) Anvendelse af en ny køleolie
DK3833662T3 (da) Inhibitorer af protein-protein-interaktionen mellem KEAP-1-NRF2-
DK3457851T3 (da) Derivater af sobetirom
DK3759745T3 (da) Dannelse af piezoelektriske anordninger
DK3474822T3 (da) Formuleringer af brincidofovir
EP3535230A4 (en) IMPROVED PERFORMANCE OF TECHNICAL CERAMICS
DK3626814T3 (da) Fremstilling af cellesfæroider
DK3600315T3 (da) Ny terapeutisk anvendelse af H3-ligander
DK3567245T3 (da) Drift af vindmølle
DK3927899T3 (da) Nedvibrering af funderinger
DK3529236T3 (da) Krystalformer af eravacyclin